Masimo Corporation

Equities

MASI

US5747951003

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-24 pm EDT			5-day change	1st Jan Change
127 ^USD	+1.80%		+2.34%	+8.35%

May. 23	Some of the biggest splits in Corporate America	RE
May. 16	Masimo and Denon Introduces White PerL and PerL Pro? Earbuds	CI

Politan Capital's Quentin Koffey Sends A Letter to Masimo Corporation CEO Joe Kiani

May 08, 2024 at 07:36 pm EDT

On May 8, 2024, Politan Capital's Quentin Koffey sent a letter to Masimo Corporation CEO Joe Kiani on May 8, 2024, demanding information about the company's proposed spinoff of. Further, Quentin Koffey stated that the company demanded directors sign a non-disclosure agreement to get basic information on the deal.

Latest news about Masimo Corporation

Some of the biggest splits in Corporate America	May. 23	RE
Masimo and Denon Introduces White PerL and PerL Pro? Earbuds	May. 16	CI
Transcript : Masimo Corporation Presents at Bank of America Health Care Conference 2024, May-15-2024 04:20 PM	May. 15
Craig Reynolds Sends the Letter to Quentin Koffey of Politan Capital	May. 13	CI
Masimo says prepared to provide one board seat to activist investor Politan	May. 09	RE
Masimo Corporation Craig Reynolds Sends a Letter to Politan Capital's Quentin Koffey	May. 09	CI
Politan Capital's Quentin Koffey Sends A Letter to Masimo Corporation CEO Joe Kiani	May. 08	CI
Politan Capital Management Threatens Masimo Corporation with Legal Action	May. 08	CI
Sector Update: Health Care Stocks Softer Late Afternoon	May. 08	MT
Sector Update: Health Care	May. 08	MT
Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set; Shares Fall	May. 08	MT
Masimo Q1 Non-GAAP Net Income, Revenue Decline; Q2 Guidance Set -- Shares Rise After Hours	May. 07	MT
Masimo Corporation Reports Earnings Results for the First Quarter Ended March 30, 2024	May. 07	CI
(MASI) MASIMO CORPORATION Forecasts Q2 Revenue Range $480M - $510M	May. 07	MT
(MASI) MASIMO CORPORATION Forecasts Fiscal Year 2024 EPS Range $3.54 - $3.70	May. 07	MT
Earnings Flash (MASI) MASIMO CORPORATION Reports Q1 Revenue $492.8M, vs. Street Est of $487.7M	May. 07	MT
Transcript : Masimo Corporation, Q1 2024 Earnings Call, May 07, 2024	May. 07
Masimo Corporation Provides Earnings Guidance for the Second Quarter 2024 and Updates Earnings Guidance for the Full-Year 2024	May. 07	CI
Masimo Obtains FDA Clearance for Over-The-Counter Version of Stork Baby Monitoring System	May. 06	MT
Masimo Receives FDA Clearance for Stork Over-the-Counter Baby Monitoring System	May. 06	CI
Masimo Insider Sold Shares Worth $5,446,616, According to a Recent SEC Filing	May. 01	MT
Stifel Upgrades Masimo to Buy From Hold, Raises Price Target to $170 From $148	Apr. 15	MT
Apple to Allow Other Payment Options for Music Apps in Europe; Appeals to Overturn Apple Watch Import Ban	Apr. 08	MT
Apple asks US appeals court to reverse Apple Watch import ban	Apr. 05	RE
Masimo Responds to Claims by Shareholder Activist Politan Capital	Apr. 01	MT

Chart Masimo Corporation

Duration

Period

More charts

Company Profile

Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-05 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Joseph Kiani, CEO of Masimo, stresses the absence of talks with Apple

January 18, 2024 at 04:47 pm EST

More Strategies

Ratings for Masimo Corporation

Trading Rating

Investor Rating

ESG Refinitiv

C-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

127 USD

Average target price

151.9 USD

Spread / Average Target

+19.60%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment

	1st Jan change	Capi.
MASIMO CORPORATION	+8.35%	6.74B
SHOCKWAVE MEDICAL, INC.	+75.35%	12.55B
PENUMBRA, INC.	-23.01%	7.51B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+14.40%	5.47B
APT MEDICAL INC.	+32.74%	4.74B
GETINGE AB	-14.85%	4.89B
ASAHI INTECC CO., LTD.	-25.57%	3.7B
INARI MEDICAL, INC.	-23.06%	2.9B
NOVOCURE LIMITED	+55.06%	2.49B
SKAN GROUP AG	+0.25%	1.99B

Medical Equipment